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Abstract
Background: Delay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated
with advanced stage and low survival. We conducted this study to learn more about the extent and reasons
behind diagnosis delay of advanced breast cancer in Moroccan women.
Methods: A group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in
Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system
delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined
as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information
and clinical data were collected on a form during an interview with each patient and from medical records.
Results: In all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of
consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was
associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of
factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy
was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of
traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000).
Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or
treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found
among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001).
Conclusions: Diagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex
interactions between several factors and with advanced stages. There is a need for improving breast cancer information
in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.
Keywords: Breast cancer, Diagnosis delay, Patient delay, System delay
Background
Breast cancer is the most frequently occurring cancer
in women all over the world with nearly a half mil-
lion deaths each year [1]. It is now the most common
cancer both in developed and developing regions. In
Morocco, breast cancer represents a serious public
health problem. It’s the first cancer among women
with a standardized incidence of 49.2 for an average
age of 50 years according to 2006–2008 data reported
by the Rabat Cancer Registry [2].
Longer waiting times prior to diagnosis and the initi-
ation of therapy are likely to result in advanced disease
and low survival [3–5]. The delayed diagnosis is more
responsible rather than the disease itself in causing mor-
tality of the patient, as early diagnosis and treatment is
associated with better prognosis when compared to
worse outcomes related to significantly delayed diagno-
sis. For example, studies in developed and developing
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countries reported that a diagnosis delay of more than
3 months occurred in 14–53 % of cases [6–15]. Low
socio-economic status, minority ethnicity and young age
were associated with a longer duration of symptoms [8].
Morocco shares the same panorama of other developing
countries, with the majority of breast cancer patients
starting treatment in advanced stages of the disease [6].
Until 2005, date of creation of Lalla Salma Foundation
against cancer (ALSC), it was commonly assumed that
this is due to the populations lack of information and to
deficient coverage of screening programs. Nevertheless,
the reasons behind always diagnostic delay of advanced
breast cancer in Morocco are varied.
Traditionally, breast cancer diagnosis delay has been
classified in two types: (1) patient delay, the interval be-
tween the discovery of symptoms and the first medical
consultation; and (2) system delay, the interval between
first consultation and definite diagnosis or treatment.
Prolonged delays usually defined as intervals greater
than 12 weeks [7]. We conducted this study to learn
more about the extent and reasons behind diagnosis
delay of advanced breast cancer in Moroccan women.
Methods
Population and study sites
This cross-sectional study was conducted during the
period from February 2014 to December 2014 at the
National Institute of Oncology in Rabat. During that
time a group of patients with advanced breast cancer
(T3 or T4 or metastatic at the time of diagnosis) were
interviewed at the institute after obtaining oral consent
from each patient. Participants were recruited either
after a computed Tomography (CT) simulation of radio-
therapy or during follow-up in the outpatient depart-
ment. Women were excluded if their breast abnormality
was discovered through breast screening or if the delay
was less than three months.
Data collection
Structured face-to-face questionnaire (Additional file 1)
were conducted by previously trained resident inter-
viewers who were not involved in the clinical management
of the patients. The supplemented information has been
filled from patient medical records. Data was collected
using a well structured checklist containing important
study parameters witch derived from the existing litera-
ture on delayed presentation in breast cancer.
The record collection includes social and demographic
data: age at presentation (years), area of residence (rural
or urban), marital status (single, married, widowed or di-
vorced), occupation (no occupation, house wife, retired,
full time or part time employed), patient (and spouse)
educational level (illiterate, primary, secondary or higher
education), number of dependent children (none, 1–3
or ≥ 4) and number of dependents (none, 1–2 or ≥ 3),
distance from basic health center (<5 km or ≥5 km), dis-
tance from specialized care (<100 km or ≥100 km).
Data includes also first clinical presenting symptoms
(breast or axillary lump, skin changes, breast pain, nipple
discharge, bone pain…), breast self-examination, family
history of breast cancer, tumor size (cm) and classifica-
tion of disease (TNM). The date of first symptoms, date
of first consultation and date of first diagnosis were col-
lected to calculate consultation time (the time taken to
visit the general practitioner after the first symptoms)
and diagnosis time (the time measured from the date of
the first medical consultation to the date of final breast
cancer diagnosis based on pathological examination).
Patient and system delay
Patient delay refers to delays occurring between the dis-
covery of symptoms and the first medical consultation,
and the most accepted threshold to establish it is three
months. System delay is that which takes place between
the first medical consultation and the definite diagnosis or
treatment, and the most accepted threshold is one month.
Factors related to patient delay (not attributed the
symptoms to cancer, fear of cancer diagnosis and/or
treatment, financial constraints, competing life priorities,
embarrassment about having a breast examination, use
of traditional methods…) and/or system delay (patient
reassured after negative physical breast examination,
mammography misinterpreted, non-specific medical
treatment without control, a negative fine-needle aspir-
ation biopsy, surgical excision without pathological
examination, not oriented to specialized service, lack of
information, appointment delay …) were collected.
Statistical analysis
Statistical analysis of the data was carried out by the SPSS
for Windows 13.0 (SPSS, Inc., Chicago, IL, USA). Qualita-
tive variables were presented as number and percentages.
Quantitative variables were presented as mean ± standard
deviation for variables with normal distribution, and as
median and interquartile range (IQR) for variables with
skewed distributions. Chi2 tests and Fisher test were used
to identify factors associated with different delays. A
multivariate logistic regression was used to determine
factors associate with longer delay. In all tests, the values
p < 0.05 were regarded statistically significant.
Results
Study population
In all, 137 patients were interviewed. The mean age of
women was 48.3 ± 10.4 years. Eighty Nine patients
(65 %) resided in urban area. Seventy seven patients
(56.2 %) were married. One hundred and fifteen patients
(83.9 %) were illiterate. Fifty two (38 %) did not have any
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dependent children. Only twenty nine patients (20.4 %)
had a family history of breast cancer. Breast or axillary
lump was a first clinical presentation in 90 (65.7 %) of
patients. Tumor size was greater than 5 cm in 91
(77.8 %) of patients. The median of consultation time
was 6[4, 12] months and the median of diagnosis time
was 1[1, 3] months. Other characteristics of the study
population (n = 137) are shown in Tables 1 and 2.
Diagnosis delay and associated factors
Table 3 reports the causes of diagnosis delay and associ-
ated factors. Among the 137 patients interviewed in this
study, 96 (70.1 %) reported a personal reason to diagno-
sis delay. From 66 (55.9 %) of patients they were not at-
tributed the first symptoms presentations to breast
cancer, 49 (41.5 %) of them thought that the absence of
pain cancer diagnosis remains unlikely and 12 (10.2 %)
of them were breastfeeding so they put all of breast
symptoms on the account of its complications. Trad-
itional therapy was applied in 15 (12.7 %) of the patients.
On the other hand, 19 (13.9 %) of patients interviewed
reports a medical reason to diagnosis delay. According
to patient perception 10 (24.4 %) were inappropriately
reassured after negative physical breast examination.
Other factors are reported in Table 3. Often the factors
related to diagnosis delay were intricate. Twenty two
(16.1 %) patients report at the same time a personal and
medical reason to diagnosis delay.
To better characterize these different factors we con-
ducted a comparative study of the social demographic
characteristics and medical history of the patients ac-
cording to the principal factors related to diagnosis delay
and according to diagnosis time, Tables 4 and 5 reports
this results respectively.
Table 1 Social demographic characteristics of the patients
(n = 137)
N (%)
Age at presentation (years) Mean (±SD) 48.3 ± 10.4
Area of residence Rural 48 (35)
Urban 89 (65)
Marital status Single 26 (19)
Married 77 (56.2)
Widowed or Divorced 34 (24.8)
Occupation No occupation 23 (16.8)
House wife 102 (74.5)
Full time employed 10 (7.3)
Part time employed 2 (1.5)













Number of dependents None 35 (25.5)
1–2 86 (62.8)
≥3 16 (11.7)








Table 2 Medical history of the patients (n = 137)
N (%)
First clinical presentations Lump 90 (65.7)
Skin changes 21 (15.3)
Breast pain 16 (11.7)
Nipple discharge 6 (4.4)
Bone pain 4 (2.9)
Breast self-examination No 115 (83.9)
Yes 22 (16.1)
Family history of breast cancer No 109 (79.6)
Yes 28 (20.4)
Consultation time or patient delay
(months)
Median [IQR] 6[4, 12]
Diagnosis time or system delay
(months)
Median [IQR] 1[1, 3]
Total diagnosis delay (months) Median [IQR] 10[5.7, 13]
Tumor characteristics
Tumor size (n = 117) ≤2 cm 3 (2.6)
3–5 cm 23 (19.7)
>5 cm 91 (77.8)
TNM classification
T T2 5 (3.6)
T3 71 (51.8)
T4 61 (44.5)




M M0 114 (83.2)
M1 23 (16.8)
Abbreviations: IQR interquartile range
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According to the principal factors related to diagnosis
delay (Table 4), a use of traditional methods was signifi-
cantly associated with rural residence and far away from
basic health and specialized care center (p = 0.001). Breast
self-examination was significantly practical in patients
who report a medical reason to diagnosis delay (p < 0.001).
Paradoxically, a family history of breast cancer was signifi-
cantly higher in who report a fear of cancer diagnosis and/
or treatment to diagnosis delay (p < 0.001).
According to total diagnosis delay; Table 5 shows the
result of univariate and multivariate logistic regression
analysis. There was a significant risk for longer delay
more than six months among rural women (univariate
OR, 16.36, 95 % CI,3.74–71.69; P < 0.001; multivariate
OR, 9.73; 95 % CI, 1.17–80.93; P = 0.035), women who
live far away from specialized care center (univariate
OR, 27.99, 95 % CI, 6.38-122.85; P < 0.001; multivariate
OR, 32.77; 95 % CI, 4.42–242.92; P = 0.001) and women
without family history of breast cancer (univariate OR,
4.99, 95 % CI, 2.07–12.00; P < 0.001; multivariate OR,
4.46; 95 % CI, 1.39–14.32; P = 0.012). Although univari-
ate analysis suggested a significant risk among women
who did not report breast self examination (OR, 3.91,
95 % CI, 1.52–10.05; P = 0.005), but this was not signifi-
cant in the multivariate model (OR, 1.20; 95 % CI, 0.37–
3.89; P = 0.765). No significant differences were found
among the other variables studied.
Discussion
In Morocco, breast cancer is the most prevalent cancer
in women and a major public health problem. Also, they
it causes a significant add up of deaths due to the delay
in their its diagnosis according to the Rabat Cancer
Registry. This is the first study conducted in our country
to learn more about the extent and reasons behind diag-
nosis delay of advanced breast cancer. Through under-
standing the causes of delay it may be possible to reduce
delays and to improve early diagnosis.
Patient’s delay has a very important contribution to a
delayed diagnosis (70.1 %). The median duration of delay
in our study was higher than in developed [8–10] or
developing countries [11–15]. About 71.5 % of symp-
tomatic patients had a delay of more than six months.
Perhaps this trend can be attributed to advanced stage
of the study population witch correlate with more diag-
nosis delay [16–19]. Living in rural area or in far
distance from specialized care was a significant predictor
of longer delay. Other studies has been shown that
women who live in larger households may have to care
for children or other dependents and thus are at higher
risk to present with late stage breast cancer [20, 21].
Also, being less educated (83.9 %) or absence of regular
breast self examination (83.9 %) within our patients sug-
gested a possible predictor of longer delay. The role of
education and knowledge in decreasing delay has been
confirmed in other studies [22–24]. A multinational ana-
lysis shows that women who made breast self examin-
ation were more educated and tended to seek medical
care more rapidly [25].
In the present study the nature of the first symp-
tom had no association with patient delay. Breast
lump was a first alarm symptom in majority of our
patients (65.7 %). However, women did not have suffi-
cient background knowledge regarding this symptom
and therefore the discovery of a breast lump did not
reduced the patient delay witch contrasted with other
studies [18, 24, 25]. The findings suggest that women
need to be educated about the different types of
breast cancer symptoms, especially the most frequent
symptom as well as encouragement to seek medical
advice if a symptom is ambiguous.
The most frequent reasons given by women for a
delayed consultation were their perception regarding
the symptoms to be harmless and temporary, adding,
that the absence of pain cancer diagnosis remains un-
likely. This demonstrates poor knowledge of our fe-
males regarding importance of these warning signs
and symptoms of breast cancer, that how much sever-
ity these symptoms can attain with the passage of
Table 3 Diagnosis delay and associated factors
N (%)
Causes of Diagnosis Delay (n = 137)
Cause related to patient 96 (70.1)
Cause related to health system 19 (13.9)
Cause related to patient and system 22 (16.1)
Factors related to patient delay (n = 118)
Symptoms not attributed to cancer 66 (55.9)
Lack of information 49 (41.5)
Symptoms related to breastfeeding 12 (10.2)
Symptoms related to benign breast disease 5 (4.2)
Use of traditional methods 15 (12.7)
Fear of cancer diagnosis and/or treatment 14 (11.9)
Financial constraints 8 (6.8)
Competing life priorities 8 (6.8)
Embarrassment about having a breast examination 7 (5.9)
Factors related to system delay (n = 41)
Negative physical breast examination 10 (24.4)
Non-specific medical treatment without control 8 (19.5)
A negative fine-needle aspiration biopsy 8 (19.5)
Appointment delay 8 (19.5)
Mammography misinterpreted 4 (9.8)
Surgical excision without pathological examination 1 (2.4)
Lack of information 2 (4.9)
Maghous et al. BMC Cancer  (2016) 16:356 Page 4 of 8
time, being irreversible and even proving to be fatal
in late stages. This result was consistent with a simi-
lar study conducted in Tunisia [11], in Libya [12], in
Nigeria [13] and others [7, 26].
Despite of the fact that awareness in our population
regarding medical health care has increased as com-
pared to past especially after creation of Lalla Salma
Foundation against cancer (ALSC), still a large part of
women initially prefer use of traditional methods,
which represent 12.7 % of the respondents in current
study, this is consistent with a regional study that
found antecedent use of unconventional and alterna-
tive therapies before seeking any medical advice as an
important reason for Patient’s delay [11, 12]. Most pa-
tients took alternative treatment as means to avoid
surgery. Some patients believed that there were no ef-
fective treatments for breast cancer, or that traditional
medicines are more effective than modern drugs. This
Table 4 Comparison of patients according to the principal cause of delay
Symptoms not attributed










Age at presentation (years) Mean (±SD) 47.74 ± 9.77 45.46 ± 9.56 44 ± 11.19 47.47 ± 10.4 0.852
Area of residence Rural 18 (34) 12 (92.3) 1 (9.1) 4 (21.1) 0.001
Urban 35 (66) 1 (7.7) 10 (90.9) 15 (78.9)
Marital status Single 10 (18.9) 3 (23.1) 5 (45.4) 5 (26.3) 0.535
Married 30 (56.6) 9 (69.2) 5 (45.4) 10 (52.6)
Widowed/Divorced 13 (24.5) 1 (7.7) 1 (9.1) 4 (21.1)
Occupation No occupation 9 (17) 3 (23.1) 4 (36.4) 4 (21.1) 0.234
House wife 41 (77.4) 10 (76.9) 5 (45.5) 12 (63.2)
Employed 3 (5.7) 0 (0.0) 2 (18.2) 3 (15.8)
Patient educational level Illiterate 45 (84.9) 13 (100) 8 (72.7) 15 (78.9) 0.222
Literate 8 (15.1) 0 (0.0) 3 (27.3) 4 (21.1)
Spouse educational level Illiterate 19 (63.3) 9 (100) 3 (60) 5 (50) 0.077
Literate 11 (36.7) 0 (0.0) 2 (40) 5 (50)
Number of dependent
children
None 20 (37.7) 5 (38.5) 7 (63.6) 8 (42.1) 0.813
1–3 21 (39.6) 5 (38.5) 2 (18.2) 8 (42.1)
≥4 12 (22.6) 3 (23.1) 2 (18.2) 3 (15.8)
Number of dependents None 13 (24.5) 3 (23.1) 4 (36.4) 5 (26.3) 0.895
1–2 35 (66) 9 (69.2) 5 (45.5) 12 (63.2)
≥3 5 (9.4) 1 (7.7) 2 (18.2) 2 (10.5)
Distance from basic health
center (km)
<5 42 (79.2) 3 (23.1) 9 (81.8) 15 (78.9) 0.001
≥5 11 (20.8) 10 (76.9) 2 (18.2) 4 (21.1)
Distance from specialized care
(km)
<100 33 (62.3) 0 (0.0) 8 (72.7) 14 (73.7) <0.001
≥100 20 (37.7) 13 (100) 3 (27.3) 5 (26.3)
Medical history of the patients
First clinical presentations Lump 31 (58.5) 10 (76.9) 7 (63.6) 13 (68.4) 0.655
Other 22 (41.5) 3 (23.1) 4 (36.4) 6 (31.6)
Breast self-examination No 50 (94.3) 13 (100) 9 (81.8) 7 (36.8) <0.001
Yes 3 (5.7) 0 (0.0) 2 (18.2) 12 (63.2)
Family history of breast
cancer
No 50 (94.3) 12 (92.3) 2 (18.2) 11 (57.9) <0.001
Yes 3 (5.7) 1 (7.7) 9 (81.8) 8 (42.1)
Numbers in bodface = significant results
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conviction was significantly associated with rural resi-
dence and far away from basic health and specialized
care center. Low socioeconomic status was one of the
factors for delay in diagnosis [27].
This study showed that a fear of cancer diagnosis
and/or treatment (11.9 %) paradoxically caused delays
as in developing countries [11–13]; especially in who
report a family history of breast cancer (81.8 %).
Table 5 Comparison of patients according to diagnosis delay





OR 95 % CI P value OR 95 % CI P value
Social demographic characteristics of the patients
Age at presentation (years) Mean (±SD) 47.7 ± 10.39 48.53 ± 10.47 1.00 0.972–1.04 0.699
Area of residence Rural 2 (5.1) 46 (46.9) 16.36 3.74–71.69 <0.001 9.73 1.17–80.93 0.035
Urban 37 (94.9) 52 (53.1) 1(Ref)
Marital status Single 9 (23.1) 17 (17.3) 1(Ref)
Married 17 (43.6) 60 (61.2) 1.87 0.71–4.93 0.207
Widowed/Divorced 13 (33.3) 21 (21.4) 0.85 0.29–2.48 0.773
Occupation No occupation 8 (20.5) 15 (15.3) 1(Ref)
House wife 26 (66.7) 76 (77.6) 1.56 0.59–4.10 0.368
Employed 5 (12.8) 7 (7.1) 0.75 0.18–3.13 0.689
Patient educational level Illiterate 17 (43.6) 98 (100) 9 109 0–< 0.001 0.999
Primary 14 (35.9) 0 (0.0) 1 0–< 0.001 1.000
Secondary/Higher 8 (20.5) 0 (0.0) 1(Ref)
Spouse educational level
(n = 77)
Illiterate 5 (29.4) 44 (73.3) 5.28 0.96–29.02 0.056
Primary 9 (52.9) 11 (18.3) 0.73 0.14–3.94 0.718
Secondary/Higher 3 (17.6) 5 (8.3) 1(Ref)
Number of dependent
children
None 17 (43.6) 35 (35.7) 1(Ref)
1–3 13 (33.3) 38 (38.8) 1.42 0.60–3.34 0.422
≥4 9 (23.1) 25 (25.5) 1.35 0.52–3.51 0.540
Number of dependents None 11 (28.2) 24 (24.5) 1(Ref)
1–2 22 (56.4) 64 (65.3) 1.33 0.56–3.16 0.513
≥3 6 (15.4) 10 (10.2) 0.76 0.22–2,64 0.670
Distance from basic
health center (km)
<5 34 (87.2) 67 (68.4) 1(Ref)
≥5 5 (12.8) 31 (31.6) 3.15 1.12–8.82 0.029 0.09 0.01–0.90 0.040
Distance from specialized
care (km)
<100 37 (94.9) 39 (39.8) 1(Ref)
≥100 2 (5.1) 59 (60.2) 27.99 6.38–122.85 <0.001 32.77 4.42–242.92 0.001
Medical history of the
patients
First clinical presentations Lump 27 (69.2) 63 (64.3) 1(Ref)
Other 12 (30.8) 35 (35.7) 1.25 0.56–2.77 0.583
Breast self-examination No 27 (69.2) 88 (89.8) 3.91 1.52–10.05 0.005 1.20 0.37–3.89 0.765
Yes 12 (30.8) 10 (10.2) 1(Ref)
Family history of breast
cancer
No 23 (59) 86 (87.8) 4.99 2.07–12.00 <0.001 4.46 1.39–14.32 0.012
Yes 16 (41) 12 (12.2) 1(Ref)
Abbreviations: OR odds ratio, 95 CI = 95 % confidence interval
Numbers in bodface = significant results
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Negative information, such as side effects and ex-
pected toxicity of chemotherapy led to fear and re-
fusal of therapy. Fear of divorce or remarriage of the
husband could lead some women to decide not to get
their symptoms diagnosed if they suspected breast
cancer. Some patients also convinced that breast can-
cer could not be cured [28], so there was no point of
having it diagnosed and treated. Diagnosis delay was
also related to a belief that mastectomy causes disfig-
urement and disability [29].
Interestingly, the present study revealed that even
breast lump was a first clinical presentation; it was not
always well assessed within nongynecologists doctors.
Our findings indicate that 24.4 % of respondents were
inappropriately reassured after the first visit to the gen-
eral practitioners that a lump can be considered benign
without biopsy. This is a false attitude. In this study,
this attitude was an important reason to the system
delay. Similar results were reported by Goodson et al.
[30]. The findings suggest that doctors also need to be
more educated about the different types of breast can-
cer symptoms and their management.
The study did not demonstrate any significant associ-
ation between age, marital status, occupation, number of
dependents and delay in diagnosis. However, several
studies have shown that older age is a predictor for pa-
tient delay but it remains controversial with marital sta-
tus [31, 32]. Occupation and number of dependents and
children had also a significant statistical correlation with
patient delay [20, 21].
In limitations, that it is worth noting there were inher-
ent in this study. The factors related to diagnosis delay
were intricate. Additionally, most of the patients were
from low socioeconomic status with majority of them
being illiterate and so the results cannot be generalized
to whole of the population.
Conclusions
In conclusion, diagnosis delay is very important health
problem in Morocco women with breast cancer which
is associated with complex interactions between several
factors. The study results do provide some understand-
ing on the topic and found that almost all of those
factors demonstrate a deficiency of sufficient know-
ledge, information and awareness in our population re-
garding this fatal disease. Moroccan women need more
education on breast cancer especially who at higher risk
of diagnosis delay, imparting adequate knowledge to its
presenting signs and symptoms, also the necessity of
regular self breast examination. Specific attention
should be conducted to increase the awareness among
general practitioners for improving breast cancer prog-
nosis by early diagnosis and treatment.
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